{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:44:51Z","timestamp":1791571491893,"version":"4.3.4"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T00:00:00Z","timestamp":1400457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      We aimed to investigate whether fasting and meal regulated glucagon like peptide 1 (\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101) secretion are altered in patients with polycystic ovary syndrome (\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      ) compared to healty women and whether oral contraceptive use influence\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101 secretion dynamics in the syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>\n                      Fourteen lean normal glucose tolerant patients with\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      and 11 age\u2010 and body mass index (\n                      <jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content>\n                      )\u2010matched healthy women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>\n                      Glucagon like peptide 1, glucose and insulin levels were measured during a standardized meal tolerance test and area under the curves (\n                      <jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content>\n                      s) were calculated. Whereas healthy controls were assessed at baseline, all tests were repeated in women with\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      after treatment with ethinyl estradiol 30\u00a0\u03bcg\/drospirenone 3\u00a0mg (\n                      <jats:styled-content style=\"fixed-case\">EE<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">DRSP<\/jats:styled-content>\n                      ) for 3\u00a0months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both fasting and post\u2010meal levels of\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101 were significantly reduced in women with\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      compared to controls (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00\u00b7022 and\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00\u00b7028, respectively).\n                      <jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content>\n                      for\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101 was also lower in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00\u00b7012). Glucose and insulin measurements did not show a significant change between the groups. In the\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      group,\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101, glucose and insulin levels did not show any change after 3\u00a0months of\n                      <jats:styled-content style=\"fixed-case\">EE<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">DRSP<\/jats:styled-content>\n                      use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101 levels both at fasting and in response to a meal are blunted in lean women with\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      compared to healthy women. Short term oral contraception do not alter\n                      <jats:styled-content style=\"fixed-case\">GLP<\/jats:styled-content>\n                      \u20101 secretion in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      . Disturbance in incretin secretion dynamics might contribute to the risk of impaired glucose tolerance and type 2 diabetes in\n                      <jats:styled-content style=\"fixed-case\">PCOS<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cen.12468","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T05:06:45Z","timestamp":1397538405000},"page":"588-592","source":"Crossref","is-referenced-by-count":34,"title":["Fasting and post\u2010prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome"],"prefix":"10.1111","volume":"81","author":[{"given":"Kadriye","family":"Aydin","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism Department of Internal Medicine Hacettepe University School of Medicine Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcan","family":"Arusoglu","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics Hacettepe University School of Health Sciences Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulden","family":"Koksal","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics Hacettepe University School of Health Sciences Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Cinar","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism Department of Internal Medicine Hacettepe University School of Medicine Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Yazgan Aksoy","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Etlik Ihtisas Research and Training Hospital Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent O.","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism Department of Internal Medicine Hacettepe University School of Medicine Ankara Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des232"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq001"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-2-492"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220405"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1370127"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/68.3.525"},{"issue":"3","key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/000456329603300303","article-title":"The entero\u2010insular axis in polycystic ovarian syndrome","volume":"33","author":"Gama R.","year":"1996","journal-title":"Annals of clinical biochemistry"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2010.2272"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0097"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2008.11.009"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.09.024"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-992931"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.008"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0601"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000172266.47820.43"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2437-9"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.01.121"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp024"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.03.007"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2009.10.016"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1896-4"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1124"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.2169\/naika.101.2698"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq301"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02427280"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12468","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T02:12:12Z","timestamp":1695521532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,19]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1111\/cen.12468"],"URL":"https:\/\/doi.org\/10.1111\/cen.12468","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,19]]}}}